AI Medical (for Jazz software) / Jazz Pharmaceuticals (biopharmaceutical company)

Dublin, Ireland  All Ireland companies → — Founded 2003
Biotech / Drug Discovery Healthcare Conglomerate Specialty-Focused AI
Public
Claim this company

Products

Jazz
AI Medical (for Jazz software) / Jazz Pharmaceuticals (biopharmaceutical company)
Neurology AI
AI Medical AG's Jazz is an FDA-cleared AI-powered software for neuroradiological image analysis, designed to assist radiologists in assessing magnetic resonance follow-up scans for conditions like multiple sclerosis and metastasis with precise lesion tracking and automated reporting.
Annual license for jazz software.

See all 1 product →

About AI Medical (for Jazz software) / Jazz Pharmaceuticals (biopharmaceutical company)

Jazz Pharmaceuticals is a global biopharmaceutical company focused on developing and commercializing innovative medicines for people with unmet medical needs, particularly in neuroscience (including sleep disorders and rare epilepsies) and oncology. The company aims to address challenging, complex diseases by keeping patients at the center of their work and connecting patients with scientific advancements.

In the realm of healthcare AI, Jazz Pharmaceuticals has been actively integrating artificial intelligence into its operations to enhance efficiency and address strategic challenges. For instance, they have successfully piloted AI projects for tasks like creating Veeva-approved branded reprint carriers and conducting medical competitor landscape analyses, demonstrating significant cost and time savings. This pioneering use of AI in the pharmaceutical industry positions Jazz as a leader in AI adoption, setting new benchmarks for efficiency and insights. Their ‘Jazz’ software, specifically for neuroradiology, utilizes intelligent automation and AI to streamline neuroimaging workflows and improve the assessment of complex brain pathologies such as chronic multiple sclerosis or multi-metastatic brain disease.

Jazz Pharmaceuticals’ diverse commercial portfolio includes treatments for rare sleep disorders like idiopathic hypersomnia and narcolepsy, and rare epilepsies such as Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. In oncology, their focus areas include extensive stage small cell lung cancer, biliary tract cancer, diffuse midline glioma, acute leukemias (ALL and AML), and veno-occlusive disease (VOD) following hematopoietic stem cell transplantation. They are committed to developing new medicines where options are limited, benefiting patient populations with high unmet needs.

Focus Areas

neuroscience oncology rare sleep disorders rare epilepsies rare cancers hematologic malignancies

What Physicians Need to Know

Neuroscience & Rare Sleep Disorders
Jazz Pharmaceuticals is a leader in therapies for rare sleep disorders like narcolepsy and idiopathic hypersomnia. Their focus extends to severe epilepsies, including Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. AI Medical's Jazz software uses intelligent automation for neuroradiology, streamlining neuroimaging and improving the assessment of complex brain pathologies such as multiple sclerosis and multi-metastatic brain disease.
Oncology & Hematologic Malignancies
Jazz Pharmaceuticals specializes in oncology, particularly in selected hematology and solid-tumor niches, rather than a broad oncology portfolio. Their focus areas include extensive stage small cell lung cancer, biliary tract cancer, diffuse midline glioma, acute leukemias (ALL and AML), and veno-occlusive disease (VOD) following hematopoietic stem cell transplantation. Key products include Rylaze for acute lymphoblastic leukemia/lymphoblastic lymphoma and Zepzelca.
Key Differentiators
Jazz Pharmaceuticals emphasizes a patient-focused, science-driven approach, prioritizing the development of new medicines for rare diseases with limited or no suitable treatment options. They employ a quantitative drug development approach, centralizing data science functions to break down silos and leverage real-world data for patient benefit. AI Medical's Jazz software differentiates itself by automating low-level tasks in neuroradiology, increasing speed, precision, and efficiency in brain scan assessment and lesion tracking.
Technology Stack
Jazz Pharmaceuticals utilizes Salesforce, AWS, and SQL Server for enterprise-grade data infrastructure, supporting commercial, clinical, and regulatory workflows. They also adopt Veeva eTMF and CTMS for clinical operations. AI Medical's Jazz software combines artificial intelligence with workflow automation for neuroimaging. Jazz Pharmaceuticals is also integrating generative AI into its operations to address strategic challenges, demonstrating a commitment to AI adoption in pharma.
Physician Tip

For physicians, AI Medical's Jazz software offers intelligent automation for magnetic resonance brain scan assessment, significantly speeding up reading times and providing factual data for precision medicine. It automates lesion annotations, volume measurements, and counts, allowing radiologists and radio-oncologists to focus more on image assessment and precise diagnoses. Jazz Pharmaceuticals provides medical information and support for healthcare professionals regarding their products. They also offer educational grants to support clinicians in navigating complex care pathways for chronic epilepsy patients and understanding cannabinoid science.

AI Medical's Jazz software integrates seamlessly into the clinical workflow of radiologists and radio-oncologists. Jazz Pharmaceuticals leverages AWS integration for scalable Salesforce analytics and utilizes Veeva Clinical for eTMF and CTMS, allowing for automated filing of monitoring reports. The company is actively exploring and integrating AI technologies to enhance operational efficiency and insights.

Products by AI Medical (for Jazz software) / Jazz Pharmaceuticals (biopharmaceutical company)

1 product in the directory

Jazz
AI Medical (for Jazz software) / Jazz Pharmaceuticals (biopharmaceutical company)
Neurology AI
AI Medical AG's Jazz is an FDA-cleared AI-powered software for neuroradiological image analysis, designed to assist radiologists in assessing magnetic resonance follow-up scans for conditions like multiple sclerosis and metastasis with precise lesion tracking and automated reporting.
Annual license for jazz software.

What the Web Says

Jazz Pharmaceuticals is a biopharmaceutical company that develops and commercializes medicines for serious diseases, with a focus on sleep disorders and oncology. While some employees praise the company's commitment to innovation, patient care, and a supportive culture, there are also concerns raised about understaffed teams, organizational changes, and perceived issues with product pricing and patient support. The company also has a software product called Jazz, which is described as intelligent automation software for neuroradiology, combining AI with workflow automation to streamline neuroimaging. However, specific reviews for "AI Medical (for Jazz software)" are limited, with general AI medical diagnostic platforms and utilization management software appearing in search results.

Overall: Mixed

Strengths

  • Commitment to innovation and patient care.
  • Highly ethical company with a commitment to employee growth.
  • Inclusive and supportive management.
  • Competitive pay and benefits.
  • Remote-first structure offers meaningful flexibility.
  • Jazz software offers an awesome UI/UX and helps improve candidate experience.

Limitations

  • Teams can be understaffed.
  • Recent organizational changes have caused challenges and a sense of growing pains.
  • Some employees feel that outlook and environment have room for improvement.
  • Concerns about product pricing and patient support, particularly for narcolepsy medications.
  • Favoritism can be a problem at times.
  • Reporting capabilities in JazzHR are missing some dashboards and metrics.

Based on reviews from: Reddit, Comparably, Indeed.com, SimplyHired, AI Medical, G2, Capterra, Built In, BioSpace, Expertini

Last updated: 2026-10-21

Videos

News, demos, and interviews about AI Medical (for Jazz software) / Jazz Pharmaceuticals (biopharmaceutical company).

Loading videos...

Videos load interactively. If none appear, search YouTube for AI Medical (for Jazz software) / Jazz Pharmaceuticals (biopharmaceutical company) →

View all on YouTube

Press & Coverage

Investing.com
Jazz Pharmaceuticals at Citigroup Summit: Rare-Disease Push Gains Pace
Jazz Pharmaceuticals presented at Citigroup's Biopharma Back to School Summit 2026, highlighting its transition towards oncology and rare diseases, supported by record revenue and the use of AI and data analytics across various business functions. The company is using AI in finance, commercial, and clinical functions, including developing predictive models to identify patients at risk of discontinuing treatment and next-best-action systems for sales teams.
2026-09
unknown
Jazz Pharmaceuticals to Acquire Actio Biosciences for Up to USD 1.32 Billion, Gaining First‑in‑Class KCNT1 Ion Channel Inhibitor ABS‑1230 for Ultra‑Rare Epilepsy
Jazz Pharmaceuticals announced its acquisition of Actio Biosciences for an upfront payment of $820 million and up to $500 million in potential milestone payments, totaling $1.32 billion. This acquisition adds ABS-1230, a clinical-stage precision therapy for KCNT1+ epilepsy, to Jazz's pipeline.
2026-08
CHC Intelligence
FDA Seeks Input on Generative-AI Medical Devices
The FDA has initiated a public feedback process to gather information for its regulatory approach concerning generative AI-enabled medical devices. This move is seen as a significant policy signal for the broader healthcare AI ecosystem.
2026-08
PR Newswire
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
Jazz Pharmaceuticals and AbCellera have announced a collaboration focused on discovering next-generation T-cell engaging multispecific antibodies. This partnership aims to leverage advanced technologies for the development of new therapeutic options.
2026-06
Business Wire
Iambic Announces Research Collaboration with Jazz Pharmaceuticals for IAM1363 and Zanidatamab Combination Cohort in HER2-Positive Breast Cancer
Iambic Therapeutics announced a research collaboration and drug supply agreement with Jazz Pharmaceuticals to study the combination of Iambic's IAM1363 and Jazz's HER2-targeted bispecific antibody, Ziihera, in HER2-positive breast cancer patients.
2025-10
The Life Sciences Report
AI Medical App Passes Standard Student Test
An AI Medical app successfully passed a standard student test, demonstrating the growing capabilities of healthcare technology firms in developing advanced software solutions. This highlights the increasing integration of AI in medical education and diagnostics.
2024-03
Life Science Sweden
Jazz Pharmaceuticals has received the green light for Ziihera as a first-line treatment for HER2-positive advanced gastric cancer.
Jazz Pharmaceuticals received regulatory approval for Ziihera as a first-line treatment for HER2-positive advanced gastric cancer, significantly expanding the drug's market potential with projected peak sales exceeding $2 billion. This approval provides a new treatment option after over a decade with trastuzumab as the primary HER2-targeted therapy.
unknown
Le Lézard
AI Medical Technology has received CE mark ... regulatory approval in Indonesia.
AI Medical Technology has obtained CE mark approval, along with regulatory approval in Indonesia. This signifies the company's expansion into international markets for its medical technology products.
unknown

Frequently Asked Questions

AI Medical's Jazz software is designed for seamless integration with various EHR systems through standard APIs and interoperability protocols. This allows for efficient data exchange, enabling healthcare providers to access comprehensive patient information, streamline workflows, and enhance decision-making for conditions like rare epilepsies and hematologic malignancies.
Jazz Pharmaceuticals has a focused portfolio addressing rare sleep disorders and rare epilepsies, including medications like Xyrem® (sodium oxybate) and Epidiolex® (cannabidiol). These products have demonstrated significant efficacy in clinical trials, improving patient outcomes by reducing symptoms and improving quality of life for conditions such as narcolepsy and Lennox-Gastaut syndrome.
Jazz Pharmaceuticals offers comprehensive support programs for healthcare professionals, including dedicated patient access teams to assist with reimbursement and financial assistance. They also provide educational resources, medical science liaisons, and ongoing training to ensure optimal understanding and appropriate use of their therapies in areas like rare cancers and hematologic malignancies.
Jazz Pharmaceuticals and AI Medical prioritize data privacy and regulatory compliance. Their Jazz software adheres to stringent security protocols and is designed to be compliant with global data protection regulations such as HIPAA and GDPR, ensuring the secure and confidential handling of sensitive patient information in all therapeutic areas.
Jazz Pharmaceuticals actively engages in strategic partnerships and collaborations with academic institutions, research organizations, and other biopharmaceutical companies. These alliances are crucial for advancing the development of innovative therapies in neuroscience and oncology, including exploring new mechanisms of action for rare cancers and neurological disorders.
Jazz Pharmaceuticals has a strong financial foundation and a robust pipeline, indicating long-term stability. This stability supports the consistent availability of their essential medications for chronic conditions like rare sleep disorders and epilepsies, while their pricing strategies aim to balance innovation, patient access, and sustainable business practices.

Related Companies

Pe
Perimeter Medical Imaging AI
Toronto, Canada and Dallas, Texas, USA

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS
Rolle, Switzerland and Boston, Massachusetts, United States

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
NTL Healthcare
Seongnam-si, Gyeonggi-do, Republic of Korea

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]
Lumonus
Sydney, Australia

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]
Koios Care
Antwerp, Belgium

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai
Mumbai, India

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.